Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22783695 | 0.98 | ACKR3 (0.51) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL10420078 | 0.96 | HDAC3 (0.54) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL10419027 | 0.96 | HDAC3 (0.54) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL14968252 | 0.96 | HTT (0.56) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL140525 | 0.96 | HDAC3 (0.54) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL11683525 | 0.92 | HDAC3 (0.54) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL10420504 | 0.92 | HDAC3 (0.54) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8993117 | 0.92 | HDAC3 (0.54) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL3752310 | 0.89 | HDAC3 (0.57) | ACKR3HDAC3HDAC1HDAC2HDAC8 | |
| Hydrochloric Acid SCHEMBL31687512 | 0.89 | HTT (0.46) | ACKR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600711-B2 | Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors | KEZAR LIFE SCIENCES, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| CN-118355096-A | Water-soluble metal processing oil | 出光兴产株式会社 | 2024-07-16 | — | — | CN | disclosed |
| CN-113603683-B | Substituted phenyl oxazolidinones for antimicrobial treatment | 结核病药物开发全球联盟公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-112262129-B | Triazacyclododecanesulfonamide (\"TCD\") based protein secretion inhibitors | 科智生命科学公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11964949-B2 | Substituted phenyloxazolidinones for antimicrobial therapy | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| US-20230357663-A1 | WATER-SOLUBLE METALWORKING FLUID | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230348810-A1 | WATER-SOLUBLE METALWORKING FLUID | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| WO-2023162707-A1 | WATER-SOLUBLE LUBRICANT | 出光興産株式会社 | 2023-08-31 | — | — | WO | disclosed |
| EP-3765447-B1 | TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS | KEZAR LIFE SCIENCES (US) | 2023-07-12 | — | — | EP | disclosed |
| EP-3765447-B1 | TRIAZACYCLODODECANSULFONAMIDE (\"TCD\")-BASED PROTEIN SECRETION INHIBITORS | KEZAR LIFE SCIENCES (US) | 2023-07-12 | — | — | EP | disclosed |
| US-20110021687-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENEIMINES | BASF SE (DE) | 2011-01-27 | — | — | US | disclosed |
| US-20110009566-A1 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| EP-2257597-A2 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2010-12-08 | — | — | EP | disclosed |
| EP-2254949-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES | BASF SE (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2227507-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2010-09-15 | — | — | EP | disclosed |
| WO-2010028975-A2 | THERMALLY CONDUCTIVE POLYAMIDE HAVING INCREASED FLOW CAPABILITY | BASF SE (DE) | 2010-03-18 | — | — | WO | disclosed |
| WO-2009115535-A2 | POLYAMIDE NANOCOMPOSITES WITH HYPER- BRANCHED POLYETHERAMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009115536-A1 | POLYAMIDE NANOCOMPOSITES WITH HYPER-BRANCHED POLYETHYLENIMINES | BASF SE (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009077492-A2 | THERMOPLASTIC POLYAMIDES HAVING POLYETHER AMINES | BASF SE (DE) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009050094-A1 | THERMOPLASTIC POLYESTER MOLDING COMPOUNDS COMPRISING HIGHLY BRANCHED POLYETHER AMINES | BASF SE (DE) | 2009-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964949-B2 | Substituted phenyloxazolidinones for antimicrobial therapy | THPO, TBCD, OXA1L | ACKR3 1709/4885HDAC3 170/4885HDAC1 26/4885 |
| US-12600711-B2 | Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors | CD274, CD40, ICOS | ACKR3 1864/4885HDAC3 4042/4885HDAC1 4537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.